Company intelligence / Profile preview

CNT Lab

Fidenza, Parma, Italycntlab.org ↗

Ownership: Private
Development stage: Commercial

Overview

CNT Lab develops and manufactures advanced nanostructured colloidal silver products with antibacterial and antiviral properties using its patented SynthAg technology. Their solutions target infection control across multiple industries including pharmacy, agriculture, cosmetics, paints/coatings, veterinary medicine, and medical devices. The company emphasizes product customization and sustainability.

Therapeutic areas: Infectious Diseases
Modalities: NanoparticleColloidal silver-based products
Industry: Chemicals & Materials

Beyond the preview

Go deeper on CNT Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CNT Lab.

Explore the full profile